Saturday, September 24, 2005

CEO of Kalbe Farma received "The Innovation Indonesia Business Leader Award 2005"


Just recently, Mr. Johannes Setijono as CEO of Kalbefarma received "The Innovation Indonesia Business Leader Award 2005" carried out by CNBC Asia and Bank Mandiri.
The event itself was held on September 23rd, 2005.

The judging and selection process was done to 200 Indonesia Business Leaders of 2005, by a line of judges who are highly competent in their fields. It was presided by University of Chicago Graduate Business School as well as some business leaders in Asia.

At the same time, Mr. Budi Dhrama from EPM (Enseval Putra Megatrading) also received an award as one of the finalists in Top 8 Indonesia Business Leader 2005.

About this award

Another award news:
- Kalbe Snatched the Forbes Global Award
- Kalbe Farma is One of the 2003 Indonesia Business Award Winners


BAHASA INDONESIA

Friday, September 02, 2005

Kalbe Farma launched a drug for Endometriosis

Do you suffer from menstrual cramps? Now you can be relieved since PT Kalbe Farma (JSX: KLBF) has marketed a generic product meant for those who have Endometriosis. PT Kalbe Farma’s introduction of Endrolin (product brand) to various print and electronic media was done today in Jakarta. In the picture dr. Antonio Bouzad (a manufacturer from Argentina) is giving Madam Irawati Setiadi (Kalbe Farma) a symbol of Endrolin.

Period Pains
According to dr. Indra Anwar, an Ob-Gyn Specialist from RS Bunda, Menstrual Cramps or Dysmenorrhea is a menstruation disorder suffered by many women. One cause of Dysmenorrhea is Endometriosis or a growth (non-cancer) of endometrium outside the womb. Endometriosis lesion can be found in the Ovaries, Fallopian Tubes and Pelvic Cavity. It can also be found at the Ileum, Colon, Bladder even the Lungs, Spine as well as the Brain. As a result, during a time of menstruation, the areas that have lesions on them will also suffer from hemorrhage.


Endometriosis Treatment
Various ways have been done to treat Endometriosis, some of them include:
  1. By giving painkillers
  2. By giving medications for the cause
  3. Surgery
  4. Complementary Therapy


Endrolin / Leuprorelin
Endrolin which contains 3.75mg of Leuprolide Acetate works by depressing the production of Esterogen (female hormone). The hypo-estrogenic condition caused the Endometrium network in and outside the uterus to shrink.

According to an investigation, the hypo-estrogenic condition may decrease symptoms, such as Menstrual Cramps, Abdominal pain and intercourse pain, etc which usually appear because of Endometriosis.

Along with the information acquired from the Press Conference, Endrolin offers women the freedom from conditions caused by Endometriosis including Menstrual Cramps. It also has easy and convenient dosing methods, reversible and light side effects, simple dosage and inexpensive.

BAHASA INDONESIA

Saturday, July 30, 2005

Innogene Kalbiotech, a subsidiary of PT Kalbe Farma to penetrate global market


Not only does it wasn’t to be the best in the country but (at the moment "JSX: KLBF" have become the biggest Pharmaceutical company in the Jakarta Stock Exchange), T Kalbe Farma wishes to penetrate the global market, by inventing new products (internationally patented). Hence Indonesia can be proud of the original pharmaceutical drugs produced by PT Kalbe Farma. Through Innogene Kalbiotech, Kalbe Farma will become a drug development companywhich focuses on clinical development. Such is the resolution from the Press Conference held at PT Kalbe Farma’s Marketing Office on Friday, July 29th, 2005.

Innogene Kalbiotech
Innogene Kalbiotech which stands for Innovation Generator Kalbe Farma Biotechnology is a subsidiary of Pt Kalbe Farma, it started on July 8th, 2003. Based on superior science and technology, the company strive to be the best in Pharmaceutical business and invent top products which can penetrate the markets in developed countries. According to Dr Rikrik Ilyas, as Director of Innogene Kalbiotech, besides the drug developments, the company also creates innovative diagnostic equipment which requires scientific and clinical developments in Global Market. From the aspect of class therapy, Innogene specializes itself in the developments of Oncology, Critical Care, Vaccines (therapeutical & preventive) and diagnostics.

Products
Some available Biogeneric products:

  1. Hemapo , for the therapy of anemia in dialysis patients caused by kidney failure
  2. Kalferon, for chronic Hepatitis B and C patients
  3. Fimalbumin, for hypoproteinemia management, with or without edema
  4. Fimakinase, for acute miokard infarct therapy, vena cava inferior thrombosis, acute massive lung embolism , acute thrombosis and artery embolism
  5. BTXA , for the therapy of strabismus and blepharospasm caused by dystonia
  6. Mediflex, a break-through formula to ease topical transdermal arthritis pain
  7. Leucogen, a product to ease fever, which is still in evaluation process for patients with non-myeloid under chemotherapy.

BAHASA INDONESIA